Wanbury Ltd.
| BSE: 524212 | Sector: Health care |
| NSE: WANBURY | ISIN Code: INE107F01022 |
| BSE 10:42 | 22 Jun | 98.00 |
1.75 (1.82%) |
OPEN
93.15 |
HIGH
99.00 |
LOW
93.15 |
| NSE 10:37 | 22 Jun | 99.00 |
1.10 (1.12%) |
OPEN
96.50 |
HIGH
99.00 |
LOW
96.50 |
| OPEN | 93.15 |
| PREVIOUS CLOSE | 96.25 |
| VOLUME | 955 |
| 52-Week high | 115.00 |
| 52-Week low | 22.05 |
| P/E | |
| Mkt Cap.(Rs cr) | 320 |
| Buy Price | 98.00 |
| Buy Qty | 85.00 |
| Sell Price | 99.00 |
| Sell Qty | 50.00 |
Wanbury Ltd. (WANBURY) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 669.25 | -0.30 | 721.90 | 452.60 | 160573.15 |
| Divi's Lab. | 4242.55 | 0.31 | 4426.85 | 2094.60 | 112618.49 |
| Dr Reddy's Labs | 5255.15 | -0.46 | 5514.65 | 3815.80 | 87414.16 |
| Cipla | 950.30 | -1.01 | 982.05 | 621.50 | 76641.70 |
| Cadila Health. | 628.20 | -0.19 | 673.70 | 347.05 | 64308.84 |
| Aurobindo Pharma | 950.15 | -0.47 | 1063.75 | 737.90 | 55669.29 |
| Piramal Enterp. | 2455.40 | 5.70 | 2477.00 | 1049.50 | 55381.55 |
| Lupin | 1157.00 | -0.03 | 1267.50 | 828.65 | 52498.88 |
| Gland Pharma | 3125.90 | 1.80 | 3512.20 | 1701.00 | 51233.50 |
| Torrent Pharma. | 2899.75 | -0.64 | 3040.00 | 2232.00 | 49069.57 |
| Biocon | 404.35 | -0.30 | 487.70 | 363.30 | 48546.26 |
| Apollo Hospitals | 3272.50 | 1.08 | 3432.90 | 1311.70 | 47052.00 |
| Alkem Lab | 3149.30 | 0.83 | 3257.75 | 2285.00 | 37649.88 |
| Abbott India | 16485.45 | -0.42 | 17350.00 | 13970.10 | 35031.58 |
| Laurus Labs | 614.60 | 2.04 | 641.95 | 100.80 | 32979.44 |
| Dr Lal Pathlabs | 3161.40 | 0.32 | 3398.95 | 1520.00 | 26347.11 |
| Glaxosmi. Pharma | 1540.85 | 0.35 | 1805.00 | 1362.80 | 26103.54 |
| Ipca Labs. | 2004.00 | -0.25 | 2455.55 | 1586.05 | 25420.74 |
| Pfizer | 5513.10 | -0.75 | 5875.00 | 3958.80 | 25222.43 |
| Max Healthcare | 250.15 | 1.46 | 259.00 | 101.65 | 24163.24 |
Quick Links for Wanbury:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
